TITLE

Review: Metformin does not increase fatal or nonfatal lactic acidosis or blood lactate levels in type 2 diabetes mellitus

AUTHOR(S)
Sigal, Ronald J.
PUB. DATE
November 2002
SOURCE
ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p88
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses research being done on the impact of metformin on the risk for fatal and nonfatal lactic acidosis or blood lactate levels in patients with type 2 diabetes mellitus. Reference to study by S. Salpeter and colleagues; Analysis of various studies on metformin; Conclusion.
ACCESSION #
8718541

 

Related Articles

  • Erythrocyte metformin levels in patients with type 2 diabetes and varying severity of chronic kidney disease. Briet, Claire; Saraval-Gross, Marie; Kajbaf, Farshad; Fournier, Albert; Hary, Lionel; Lalau, Jean-Daniel // Clinical Kidney Journal;Jan2012, Vol. 5 Issue 1, p65 

    No abstract available.

  • Canagliflozin.  // AHFS Consumer Medication Information;Jun2017, p1 

    Canagliflozin is used along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in patients with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). Canagliflozin is in a class of...

  • Diabetic emergencies including hypoglycemia during Ramadan. Ahmad, Jamal; Pathan, Md Faruque; Jaleel, Mohammed Abdul; Fathima, Farah Naaz; Raza, Syed Abbas; Khan, A. K. Azad; Ishtiaq, Osama; Sheikh, Aisha // Indian Journal of Endocrinology & Metabolism;Jul/Aug2012, Vol. 16 Issue 4, p512 

    Majority of physicians are of the opinion that Ramadan fasting is acceptable for well-balanced type 2 patients conscious of their disease and compliant with their diet and drug intake. Fasting during Ramadan for patients with diabetes carries a risk of an assortment of complications. Islamic...

  • A comparative study of two various models of organising diabetes follow-up in public primary health care - the model influences the use of services, their quality and costs. Honkasalo, Mikko T.; Linna, Miika; Sane, Timo; Honkasalo, Atte; Elonheimo, Outi // BMC Health Services Research;2014, Vol. 14 Issue 1, p1 

    Background In Finland diabetologists have long been concerned about the level of diabetes care as the incidence of type 1 diabetes and complicated type 2 diabetes is exceeding the capacity of specialist clinics. We compared the outcome of diabetes care in two middle-sized Finnish municipalities...

  • Alogliptin.  // AHFS Consumer Medication Information;Jun2017, p1 

    Alogliptin is used along with diet and exercise to lower blood sugar levels in patients with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). Alogliptin is in a class of medications called dipeptidyl peptidase-4 (DPP-4)...

  • Canagliflozin.  // AHFS Consumer Medication Information;Jun2017, p1 

    Canagliflozin is used along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in patients with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). Canagliflozin is in a class of...

  • A Rare Presentation of Community Acquired Methicillin Resistant Staphylococcus aureus. Docekal, J.; Hall, J.; Reese, B.; Jones, J.; Ferguson, T. // Case Reports in Infectious Diseases;2013, p1 

    Prostatic abscess is a rarely described condition and is commonly caused by gram-negative organisms such as enterobacteria. However, as the prevalence of methicillin resistant Staphylococcus aureus (MRSA) increases in the community, unusual infections due to this organism have been recently...

  • Euglycemic Ketoacidosis Caused by Sodium-Glucose Cotransporter 2 Inhibitors: A Case Report. Bobart, Shane A.; Gleason, Benjamin; Martinez, Nydia; Norris, Keith; Williams, Sandra F. // Annals of Internal Medicine;10/4/2016, Vol. 165 Issue 7, p530 

    The article presents a case study of a 40 year old women with dyspnea, nausea and vomiting after cosmetic surgery and treated for SGLT-2-associated diabetic ketoacidosis (DKA) with intravenous saline, dextrose, sodium bicarbonate and insulin. Topics discussed includes canagliflozin, type 2...

  • Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients. Hanatani, Tadaaki; Sai, Kimie; Tohkin, Masahiro; Segawa, Katsunori; Saito, Yoshiro // International Journal of Clinical Pharmacy;Jun2015, Vol. 37 Issue 3, p537 

    Background The March 2012 regulatory action issued by the Japanese government signalled the rare but serious complication of lactic acidosis that can occur during metformin treatment, especially with the high dose formulation, h-metformin, and in those above 75 years old. Objective To assess...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics